Yupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet nebulizer. It’s typically ...

A nebulizer is a medical device that turns liquid medicine into mist or aerosol that you inhale directly into your lungs. Medications used to treat respiratory conditions such as asthma, cystic ...

COPD, or chronic obstructive pulmonary disease, is a group of life-changing lung diseases that include emphysema and chronic bronchitis. 1 Those living with COPD can experience coughing, wheezing, ...

(StatePoint) If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you receive can impact your health outcomes and quality of life. That ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...

(StatePoint) Managing chronic obstructive pulmonary disease (COPD) is always important, and especially so right now, as individuals living with a chronic lung disease are at a higher risk of severe ...

The first DTC ad campaign for Viatris and Theravance’s COPD nebulizer therapy Yupelri aims to show the freedom of the once-daily treatment. In a newly debuted TV ad, an older woman celebrates her ...

Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system. The SUN-101/eFlow system, described as a ...

The therapies combine three proven medicines-Glycopyrronium, Formoterol, and Budesonide-to reduce airway obstruction, control ...

Sunovion Pharmaceuticals of Marlborough announced the start of a phase 3 clinical trial program for SUN-101, an inhalation solution being investigated for the treatment of chronic obstructive ...